MA Healthcare, British Journal of Hospital Medicine, 4(67), p. 184-187, 2006
DOI: 10.12968/hmed.2006.67.4.20863
Full text: Unavailable
Psoriasis is a common, chronic immune-mediated skin disorder. Recent advances in the understanding of the immunopathogenesis of psoriasis have led to the development of biological agents designed to target the molecular mechanisms of the condition. These provide new and effective treatments for patients with moderate to severe psoriasis.